Patent US ọhụrụ maka ịchọpụta PTSD na ihe ndị dị ndụ

Neurovation Labs, Inc., ụlọ ọrụ biotech na-ezubere ndị na-ahụ maka biomarkers anụ ahụ nke PTSD maka nyocha na ọgwụgwọ zuru oke, taa mara ọkwa na US Patent and Trademark Office nyere US Patent No. 11,224,668, na Jenụwarị 18, 2022.

Print Friendly, PDF & Email

Patent ahụ, nke akpọrọ "Compositions and Methods to Detect GluA1 in Brain and to Identify the Presence of GluA1-Mediated PTSD," ka eduzi na usoro ihe omimi na ụzọ maka ịchọpụta PTSD yana ịgwọ PTSD na-eso ụdị nchoputa ahụ.              

"Ngwakọta nke patent a chebere sitere na otu n'ime usoro klaasị nke Neurovation Labs na-etolite iji mee ka nyocha ebumnuche nke PTSD na iji nyochaa usoro ndị na-akpata PTSD na nsogbu ahụike uche ndị ọzọ. Ogige ndị a na ụzọ kwekọrọ ekwekọ nke patent ahụ kpuchiri na-anọchi anya akwụkwọ akụkọ, ụzọ ezubere iche maka ahụike uche na iji anya nke uche na-ahụ maka nsogbu nke ụbụrụ na-akpata, "Dọkịta Jennifer Perusini, Co-Founder & Chief Executive Officer nke ụlọ ọrụ ahụ kwuru.

Ọ bụ naanị Neurovation Labs nwe patent a ma bụrụ nke izizi sitere na Pọtụfoliyo akụrụngwa ọgụgụ isi sara mbara sitere na nyocha na mmepe ụlọ ọrụ.

Print Friendly, PDF & Email
Enweghị akara ọ bụla maka post a.

Banyere chepụtara

nchịkọta akụkọ

Onye nchịkọta akụkọ nke eTurboNew bụ Linda Hohnholz. Ọ dabere na eTN HQ na Honolulu, Hawaii.

Ahapụ a Comment